Rugo, Hope S.; Pennella, Eduardo J.; Gopalakrishnan, Unmesh; Hernandez-Bronchud, Miguel; Herson, Jay; Koch, Hans Friedrich; Loganathan, Subramanian; Deodhar, Sarika; Marwah, Ashwani; Manikhas, Alexey; Bondarenko, Igor; Mukhametshina, Guzel; Nemsadze, Gia; Parra, Joseph D.; Abesamis-Tiambeng, Maria Luisa T.; Baramidze, Kakhaber; Akewanlop, Charuwan; Vynnychenko, Ihor; Sriuranpong, Virote; Mamillapalli, Gopichand; Roy, Sirshendu; Yanez Ruiz, Eduardo Patricio; Barve, Abhijit; Fuentes-Alburo, Adolfo; Waller, Cornelius F.

FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

FAST: 唑贝妥昔单抗 (IMAB362) 加EOX与单独EOX一线治疗晚期CLDN18.2阳性胃和胃食管腺癌的随机II期研究

ANNALS OF ONCOLOGY

IF65.4

2021-05-01238

OAAI

Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score (TPS) ≥1%: KEYNOTE-033

ANNALS OF ONCOLOGY

IF65.4

2020-09-017

OAAI

Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open -label phase III study

ANNALS OF ONCOLOGY

IF65.4

2020-07-01261

OAAI

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

LANCET

IF88.5

2019-11-011.4K

PREAI

Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J.; Ozguroglu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowicz, Andrzej; Losonczy, Gyorgy; Conev, Nikolay V.; Armstrong, Jon; Byrne, Natalie; Shire, Norah; Jiang, Haiyi; Goldman, Jonathan W.; Batagelj, Emilio; Casarini, Ignacio; Pastor, Anea Viviana; Sena, Susana Noemi; Zarba, Juan Jose; Burghuber, Otto; Hartl, Sylvia; Hochmair, Maximilian J.; Lamprecht, Bernd; Studnicka, Michael; Schlittler, Luis Alberto; de Oliveira, Fabricio Augusto Martinelli; Calabrich, Aknar; Girotto, Gustavo Colagiovanni; Dos Reis, Peo; Gorini, Carlos Fausto Nino; De Marchi, Peo Rafael Martins; Baldotto, Clarissa Serodio da Rocha; Sette, Claudia; Zukin, Mauro; Conev, Nikolay V.; Dudov, Assen; Ilieva, Rumyana; Koynov, Krassimir; Krasteva, Rositsa; Tonev, Ivan; Valev, Spartak; Venkova, Violetka; Bi, Minghong; Chen, Chengshui; Chen, Yuan; Chen, Zhendong; Fang, Jian; Feng, Jifeng; Han, Zhigang; Hu, Jie; Hu, Yi; Li, Wei; Liang, Zongan; Lin, Zhong; Ma, Rui; Ma, Shenglin; Nan, Kejun; Shu, Yongqian; Wang, Kai; Wang, Mengzhao; Wu, Gang; Yang, Nong; Yang, Zhixiong; Zhang, Helong; Zhang, Wei; Zhao, Jun; Zhao, Yanqiu; Zhou, Caicun; Zhou, Jianying; Zhou, Xiangdong; Havel, Libor; Kolek, Vitezslav; Koubkova, Leona; Roubec, Jaromir; Skrickova, Jana; Zemanova, Milada; Chouaid, Christos; Hilgers, Werner; Lena, Herve; Moro-Sibilot, Denis; Robinet, Gilles; Souquet, Pierre-Jean; Alt, Jurgen; Bischoff, Helge; Grohe, Christian; Laack, Eckart; Lang, Susanne; Panse, Jens; Reinmuth, Niels; Schulz, Christian; Bogos, Krisztina; Csanky, Eszter; Fulop, Anea; Horvath, Zsolt; Kosa, Judit; Laczo, Ibolya; Losonczy, Gyorgy; Pajkos, Gabor; Papai, Zsuzsanna; Szekely, Zsolt Papai; Sarosi, Veronika; Somfay, Attila; Ezer, Eva Somogyine; Telekes, Anas; Bar, Jair; Gottfried, Maya; Heching, Norman Isaac; Kuch, Alona Zer; Bartolucci, Roberta; Bettini, Anna Cecilia; Delmonte, Angelo; Garassino, Marina Chiara; Minelli, Mauro; Roila, Fausto; Verderame, Francesco; Atagi, Shinji; Azuma, Koichi; Goto, Hisatsugu; Goto, Koichi; Hara, Yu; Hayashi, Hidetoshi; Hida, Toyoaki; Hotta, Katsuyuki; Kanazawa, Kenya; Kanda, Shintaro; Kim, Young Hak; Kuyama, Shoichi; Maeda, Tadashi; Morise, Masahiro; Nakahara, Yasuharu; Nishio, Makoto; Nogami, Naoyuki; Okamoto, Isamu; Saito, Haruhiro; Shinoda, Masahiro; Umemura, Shigeki; Yoshida, Tatsuya; Claessens, Niels; Cornelissen, Robin; Heniks, Lizza; Hiltermann, Jeroen; Smit, Egbert; van den Brekel, Agnes Staal; Kazarnowicz, Andrzej; Kowalski, Dariusz; Mandziuk, Slawomir; Mroz, Robert; Wojtukiewicz, Marek; Ciuleanu, Tudor; Ganea, Doina; Ungureanu, Anei; Dvorkin, Mikhail; Luft, Alexander; Moiseenko, Vladimir; Poltoratskiy, Artem; Sakaeva, Dina; Smolin, Alexey; Statsenko, Galina; Vasilyev, Alexander; Vladimirova, Lyubov; Anasina, Igor; Chovanec, Jozef; Demo, Pavol; Godal, Robert; Kasan, Peter; Stresko, Marian; Urda, Michal; Cho, Eun Kyung; Ji, Jun Ho; Kim, Joo-Hang; Kim, Sang-We; Lee, Gyeong-Won; Lee, Jong-Seok; Lee, Ki Hyeong; Lee, Kyung Hee; Lee, Yun Gyoo; Molla, Maria Amelia Insa; Gomez, Manuel Domine; Mingorance, Juan Ignacio Delgado; Casado, Dolores Isla; Brea, Marta Lopez; Tarruella, Margarita Majem; Bueno, Teresa Moran; Mendivil, Alejano Navarro; Rodriguez, Luis Paz-Ares; Aix, Santiago Ponce; Campelo, Maria Rosario Garcia; Chang, Gee-Chen; Chen, Yen-Hsun; Chiu, Chao-Hua; Hsia, Te-Chun; Lee, Kang-Yun; Li, Chien-Te; Wang, Chin-Chou; Wei, Yu-Feng; Wu, Shang-Yin; Alacacioglu, Ahmet; Cicin, Irfan; Demirkazik, Ahmet; Erman, Mustafa; Goksel, Tuncay; Ozguroglu, Mustafa; Adamchuk, Hryhoriy; Bondarenko, Igor; Kolesnik, Oleksii; Kryzhanivska, Anna; Ostapenko, Yuriv; Shevnia, Serhii; Shparyk, Yaroslav; Trukhin, Dmytro; Ursol, Grygorii; Voitko, Nataliia; Voitko, Oleksandr; Vynnychenko, Ihor; Babu, Sunil; Chen, Yuanbin; Chiang, Anne; Chua, Winston; Dakhil, Shaker; Dowlati, Afshin; Goldman, Jonathan W.; Haque, Basir; Jamil, Rodney; Knoble, Jeanna; Lakhanpal, Shailena; Mi, Kailhong; Nikolinakos, Petros; Powell, Steven; Ross, Helen; Schaefer, Eric; Schneider, Jeffrey; Spahr, Joseph; Spigel, David; Stilwill, Joseph; Sumey, Christopher; Williamson, Michael

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

帕博利珠单抗联合阿西替尼与舒尼替尼治疗晚期肾细胞癌的比较

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2019-03-212.4K

OAAI

HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin

EUROPEAN JOURNAL OF CANCER

IF7.1

2017-02-011

PREAI

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer A Randomized Clinical Trial